Page 22 - Lipids News Today

The lipidomic changes during Ramadan diurnal intermittent fasting (RIF) among obese individuals.

Participants taking estetrol experienced beneficial changes across a variety of metabolic measures, according to a new study presented at the Menopause Society.

Unlike tirzepatide, which combines weight loss and glucose-lowering properties, this twincretin reduces liver fat along with weight, blood pressure, and lipid levels.

Atrial fibrillation will now be included as a common side effect in the Summary of Product Characteristics for medicinal products containing omega-3-acid ethyl esters.

"Good" cholesterol at low or high levels is linked to dementia risk in older adults, but there was no association between dementia and levels of "bad" cholesterol

A new diagnosis of type 2 diabetes is associated with increased 10-year risk of cardiovascular disease in both sexes and across all age groups, but particularly in those younger than 40, research shows.

A novel amino acid transporter-based therapeutic target for pancreatic ductal adenocarcinoma (PDAC).

If clinicians are uncomfortable addressing use of anabolic-androgen steroids, patients will continue to look to each other and the internet to fill the void.

Struggles with housing and food security as well as concerns about medication side effects appear to exacerbate a lack of medication adherence.

Taking longer between first and last meals of the day may indirectly improve metabolic health for some heart failure patients, propose researchers from preliminary findings that go against intermittent fasting.